No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Induction chemotherapy with docetaxel, cisplatin, and cetuximab offers similar outcomes with a potentially more favorable treatment schedule than 5-fluorouracil

byTeddy Guo

October 14, 2021

in StudyGraphics

Reading Time: 1 min read

Click to read this study in the European Journal of Cancer.

RELATED REPORTS

Pembrolizumab improves survival in locally advanced head and neck cancer

#VisualAbstract: Neoadjuvant and Adjuvant Pembroli-zumab Increased Survival in Locally Advanced Head and Neck Cancer

#VisualAbstract: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

Wellness Check: Nutrition

RelatedReports

Elective neck dissection may be unnecessary for adenoid cystic carcinoma

Oncology

Pembrolizumab improves survival in locally advanced head and neck cancer

August 26, 2025

StudyGraphics

#VisualAbstract: Neoadjuvant and Adjuvant Pembroli-zumab Increased Survival in Locally Advanced Head and Neck Cancer

July 18, 2025

StudyGraphics

#VisualAbstract: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

July 9, 2025

StudyGraphics

#VisualAbstract: Encorafenib, Cetuximab, and mFOLFOX6 Improves Survival in BRAF-Mutated Colorectal Cancer

June 13, 2025

Early palliative care may improve survival in advanced cancer

Fractional carbon dioxide laser not effective for treatment of postmenopausal vaginal symptoms

The Most Outrageous Kim Khasyian Outfits of All Time

Strict tobacco licensing laws linked to reduced adolescent smoking initiation

Smoking prior to open and endovascular revascularization associated with increased post-procedural complications

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result